B Bilgin Global Mod Global Mod 13 Şub 2024 #1 Eris Lifesciences acquires 51% stake in Swiss Parenterals for ₹637.50 crore Acquiring Swiss Parenterals will bolster the company's domestic presence with a new injectables-focused branded formulations business and enhance reach in emerging markets
Eris Lifesciences acquires 51% stake in Swiss Parenterals for ₹637.50 crore Acquiring Swiss Parenterals will bolster the company's domestic presence with a new injectables-focused branded formulations business and enhance reach in emerging markets
